Updates

Volex

May 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Volex shares have been a strong market after saying it expects full-year sales to end March of US$392m, up US$20m on the year. Net cash is US$31.7m. It said that the impact of COVID-19 has been mitigated by its defensive exposure to medical devices and data-centre products (which are in even greater demand as much of the world's population works from home), which make up two-thirds of its complex assemblies division. The shares have bounced to pre-COVID levels very quickly. Strong hold. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Everyman Media

SDI Group

Volex - To benefit from Trump’s lower US tax and autonomous vehicles (December 2024)

Volex - Organic sales and margins ahead of expectations (November 2024)

Volex - Investment driven by localisation (August 2024)

Volex (May 2024)

Volex (December 2023)

Volex (November 2023)

Volex - Murat Ticaret deal completes earlier than anticipated (September 2023)

Volex - Transformational deal produces 14% eps upgrade (July 2023)

Volex - Trading ahead of expectations (May 2023)

Volex - Outperforming the market (December 2022)

Volex - Strong Q1 trading (September 2022)

Volex - To bust a billion within five years (July 2022)

Volex - EV demand helps it beat expectations (May 2022)

Volex - Enters EV infrastructure segment (December 2021)

Volex - Two directors buy shares (November 2021)

Volex - Earnings accretive US defence acquisition (September 2021)

Volex - Forecast up 5% as Medical and EV jump (August 2021)

Volex - Data centres and EV sales +38% and +193%, respectively (July 2021)

Volex - Significant beat on FY21 estimates (May 2021)

Volex (March 2021)

Volex - Three deals being worked on (January 2021)

Volex - Canaccord sets 398p price target (December 2020)

Volex - "Materially ahead of expectations"- results due on 12 November (November 2020)

Volex (August 2020)

Volex - High growth and exciting (December 2019)

Volex - Five quarters of improvement (June 2010)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X